Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-24APM3Kira Sheinerman's Form 3 Filing for Niki BioSolutions Common Stock OwnershipMEDIUM
This Form 3 filing discloses the initial statement of beneficial ownership of securities by Kira Sheinerman, a director and greater than 10% owner of Niki BioSolutions, Inc. (ticker: NIKI). The filing shows Sheinerman owns 1,515,293 shares of common stock as of July 20, 2026. Of these shares, 1,515,016 are held directl...
Nano CapBiotechnology
2026-07-24APM3Insider Transaction: Laura A. Philips Acquires Shares in Niki BioSolutions, Inc.MEDIUM
This filing reports a transaction by Laura A. Philips, a director at Niki BioSolutions, Inc. (NIKI). The transaction, dated July 20, 2026, involves the acquisition of common stock. Following this transaction, Ms. Philips directly owns 6,024 shares of the company's common stock. The filing is made in accordance with SEC...
Nano CapBiotechnology
2026-07-24Niki BioSolutions, Inc.3Insider Transaction: Laura A. Philips Acquires Shares in Niki BioSolutions, Inc.DuplicateMEDIUM
This filing reports a transaction by Laura A. Philips, a director at Niki BioSolutions, Inc. (NIKI). The transaction, dated July 20, 2026, involves the acquisition of common stock. Following this transaction, Ms. Philips directly owns 6,024 shares of the company's common stock. The filing is made in accordance with SEC...
Nano CapBiotechnology
2026-07-24Niki BioSolutions, Inc.3Kira Sheinerman's Form 3 Filing for Niki BioSolutions Common Stock OwnershipDuplicateMEDIUM
This Form 3 filing discloses the initial statement of beneficial ownership of securities by Kira Sheinerman, a director and greater than 10% owner of Niki BioSolutions, Inc. (ticker: NIKI). The filing shows Sheinerman owns 1,515,293 shares of common stock as of July 20, 2026. Of these shares, 1,515,016 are held directl...
Nano CapBiotechnology
2026-07-24APLM3Initial Statement of Beneficial Ownership - Apollomics Inc.MEDIUM
This filing is an Initial Statement of Beneficial Ownership for Apollomics Inc. (APLM), filed by Yen Hung Hsien, a director. The filing is in connection with the Holding Foreign Insiders Accountable Act. On July 20, 2026, Yen Hung Hsien was granted 500 restricted stock units, which are set to vest on September 15, 2026...
Nano CapBiotechnology
2026-07-23JSPR3Power of Attorney and Stock Option Grant for Greg KeenanMEDIUM
This filing details a Power of Attorney granted by Greg Keenan, Chief Medical Officer of Jasper Therapeutics, Inc., to Herb Cross and Jeetinder Singh Mahal, authorizing them to act on his behalf for SEC filings. The filing also reports on stock options granted to Keenan as a result of a merger between Jasper Therapeuti...
Nano CapBiotechnology
2026-07-23Jasper Therapeutics, Inc.3Power of Attorney and Stock Option Grant for Greg KeenanDuplicateMEDIUM
This filing details a Power of Attorney granted by Greg Keenan, Chief Medical Officer of Jasper Therapeutics, Inc., to Herb Cross and Jeetinder Singh Mahal, authorizing them to act on his behalf for SEC filings. The filing also reports on stock options granted to Keenan as a result of a merger between Jasper Therapeuti...
Nano CapBiotechnology
Sponsored